A Study of Hospital-at-Home for People Receiving Tarlatamab

Part of paid clinical trials in Basking Ridge, New Jersey.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT06957314
Status
Recruiting

Conditions

  • Small Cell Lung Carcinoma
  • Small-cell Lung Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Hospital-at-Home/HAH — OTHER
    After discharge, a SeniorCare community paramedic will provide a home visit to the participant's home or residence

Study Details

The purpose of this study is to find out whether a Hospital-at-Home (HaH) program is a more efficient way to monitor people's health after receiving tarlatamab than monitoring in the hospital (inpatient).

Key Dates

Start date
Apr 23, 2025
Status verified
Mar 2026
Primary completion
Apr 23, 2028
Completion
Apr 23, 2028

Study Design

Enrollment
70 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • No Intervention: Control Arm
    Participants randomized to the control group will receive tarlatamab administration as per usual care.
  • Experimental: Hospital-at-Home/HAH Intervention Arm
    Participants randomized to the intervention group will receive tarlatamab administration through the hospital-at-home care delivery model.

Primary Outcome Measure

Number of inpatient hospital days [ Time Frame: 14 days ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)Basking RidgeNew Jersey07920
Robert Daly, MD, MBA
646-608-3789
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)MiddletownNew Jersey07748
Robert Daly, MD, MBA
646-608-3789
Memorial Sloan Kettering Bergen (Limited Protocol Activities)MontvaleNew Jersey07645
Robert Daly, MD, MBA
646-608-3789
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities)CommackNew York11725
Robert Daly, MD, MBA
646-608-3789
Memorial Sloan Kettering Westchester (Limited Protocol Activities)HarrisonNew York10604
Robert Daly, MD, MBA
646-608-3789
Memorial Sloan Kettering Cancer Center (All Protocol Activites)New YorkNew York10065
Robert Daly, MD, MBA
646-608-3789
Memorial Sloan Kettering Nassau (Limited Protocol Activities)UniondaleNew York11553
Robert Daly, MD, MBA
646-608-3789

Find similar trials in Basking Ridge, NJ

Related Studies